Suppr超能文献

动脉粥样硬化性心血管疾病风险评估中的风险增强因素和健康的社会决定因素。

Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.

机构信息

Division of General Medicine, Columbia University Irving Medical Center, New York, NY, United States of America.

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America.

出版信息

PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024.

Abstract

BACKGROUND

The Pooled Cohort Equations (PCEs) do not accurately estimate atherosclerotic cardiovascular disease (ASCVD) risk in certain populations. The 2018 AHA/ACC cholesterol guideline identified risk-enhancing factors as a supplement to PCEs-based risk assessment. However, the role of each risk-enhancing factor in ASCVD risk assessment has not been well quantified. Further, social determinants of health (SDOH) are not included in the PCEs nor considered as risk-enhancing factors in the US cholesterol guideline. We sought to evaluate ASCVD risk associated with each risk-enhancing factor and commonly collected SDOH including education, income, and employment status, and to assess if adding risk-enhancing factors and SDOH to the PCEs improve ASCVD risk prediction.

METHODS

We included individuals aged 40 to 75 years, without ASCVD or diabetes at baseline, and with low-density lipoprotein cholesterol 70-189 mg/dL from two contemporary prospective cohort studies (MESA and REGARDS) and from Kaiser Permanente Southern California (KPSC). The primary endpoint was incident ASCVD defined as nonfatal myocardial infarction, fatal coronary heart disease, or fatal or nonfatal stroke over a 10-year period (median follow-up 10 years). We used Cox proportional hazards models to estimate associations between risk-enhancing factors and SDOH with ASCVD. We also assessed changes in model performance after adding risk-enhancing factors and SDOH to the PCEs.

RESULTS

We included 13,863 adults (mean age 60.7 years) from the prospective cohorts and 307,931 adults (mean age 54.8 years) from KPSC. Risk-enhancing factors including hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, and chronic kidney disease were associated with a higher ASCVD risk, independent of 10-year risk estimated by the PCEs. Low education, low income, and unemployment were also associated with higher ASCVD risk. While adding individual risk-enhancing factors or SDOH to the PCEs had limited impact on model performance, adding multiple risk-enhancing factors and SDOH simultaneously led to modest improvements in discrimination (C-index increased by up to 0.07), calibration (integrated Brier score reduced by up to 2.3%), and net reclassification improvement up to 41.4%.

CONCLUSIONS

These findings suggest including SDOH and risk-enhancing factors may improve ASCVD risk assessment.

摘要

背景

Pooled Cohort Equations(PCEs)不能准确估计某些人群的动脉粥样硬化性心血管疾病(ASCVD)风险。2018 年 AHA/ACC 胆固醇指南将风险增强因素确定为 PCE 为基础的风险评估的补充。然而,每个风险增强因素在 ASCVD 风险评估中的作用尚未得到很好的量化。此外,健康的社会决定因素(SDOH)并未包含在 PCEs 中,也未被视为美国胆固醇指南中的风险增强因素。我们试图评估与每个风险增强因素以及包括教育、收入和就业状况在内的常见社会决定因素相关的 ASCVD 风险,并评估将风险增强因素和 SDOH 添加到 PCEs 是否可以改善 ASCVD 风险预测。

方法

我们纳入了来自两个当代前瞻性队列研究(MESA 和 REGARDS)和 Kaiser Permanente Southern California(KPSC)的年龄在 40 至 75 岁之间、基线时无 ASCVD 或糖尿病且低密度脂蛋白胆固醇在 70-189mg/dL 的个体。主要终点是在 10 年内发生的 ASCVD,定义为非致命性心肌梗死、致命性冠心病或致命性或非致命性中风。我们使用 Cox 比例风险模型来估计风险增强因素和 SDOH 与 ASCVD 之间的关联。我们还评估了在将风险增强因素和 SDOH 添加到 PCEs 后模型性能的变化。

结果

我们纳入了来自前瞻性队列的 13863 名成年人(平均年龄 60.7 岁)和来自 KPSC 的 307931 名成年人(平均年龄 54.8 岁)。包括高胆固醇血症、高三酰甘油血症、代谢综合征和慢性肾病在内的风险增强因素与 ASCVD 风险增加相关,独立于 PCEs 估计的 10 年风险。低教育、低收入和失业也与 ASCVD 风险增加相关。虽然将单个风险增强因素或 SDOH 添加到 PCEs 对模型性能的影响有限,但同时添加多个风险增强因素和 SDOH 可适度提高区分度(C 指数最多增加 0.07)、校准度(综合 Brier 评分最多降低 2.3%)和净重新分类改善率高达 41.4%。

结论

这些发现表明,包括 SDOH 和风险增强因素可能会改善 ASCVD 风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b1f/11508156/2e738a1d96cd/pone.0312756.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验